The Supreme Court's decision to uphold Tennessee's ban on gender-affirming care for minors has broader implications, impacting nearly half of the United States. The Dutch Protocol, which originally guided this care, emphasized a structured approach involving puberty blockers, hormones, and surgeries. However, shifts since 2015 have seen quicker treatment starts in some clinics, raising questions about evidence-based practices. In the UK, the Cass Review led to scaled-back care due to weak evidence, while Germany continues to support such care based on clinical experience. In the U.S., political debates have intensified, with medical groups opposing bans despite political pressures. Parents face significant challenges as they navigate these bans, which disrupt essential care for their children and halt crucial research. The patchwork of laws across the country adds to the confusion and fear among families seeking appropriate medical support.